These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 23388095

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. TiProtec preserves endothelial function in a rat model.
    Veres G, Hegedűs P, Barnucz E, Schmidt H, Radovits T, Zöller R, Karck M, Szabó G.
    J Surg Res; 2016 Jan; 200(1):346-55. PubMed ID: 26219206
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of Prolyl Hydroxylase Attenuates Fas Ligand-Induced Apoptosis and Lung Injury in Mice.
    Nagamine Y, Tojo K, Yazawa T, Takaki S, Baba Y, Goto T, Kurahashi K.
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):878-888. PubMed ID: 27494234
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury.
    Zhao X, Jin Y, Li H, Wang Z, Zhang W, Feng C.
    Int J Clin Exp Pathol; 2014 Dec; 7(6):3081-8. PubMed ID: 25031727
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells.
    Takaku M, Tomita S, Kurobe H, Kihira Y, Morimoto A, Higashida M, Ikeda Y, Ushiyama A, Hashimoto I, Nakanishi H, Tamaki T.
    PLoS One; 2012 Dec; 7(8):e42964. PubMed ID: 22880134
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS, Kiriakidis S, Paleolog EM, Davies AH.
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of prolyl hydroxylase domain-containing protein downregulates vascular angiotensin II type 1 receptor.
    Matsuura H, Ichiki T, Ikeda J, Takeda K, Miyazaki R, Hashimoto T, Narabayashi E, Kitamoto S, Tokunou T, Sunagawa K.
    Hypertension; 2011 Sep; 58(3):386-93. PubMed ID: 21825224
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prolyl-hydroxylase inhibition induces SDF-1 associated with increased CXCR4+/CD11b+ subpopulations and cardiac repair.
    Ghadge SK, Messner M, Van Pham T, Doppelhammer M, Petry A, Görlach A, Husse B, Franz WM, Zaruba MM.
    J Mol Med (Berl); 2017 Aug; 95(8):825-837. PubMed ID: 28550361
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.